Evidence map›Paper›PMID 42238751›Full record

ReviewBasic and clinical neuroscience2025

Unequal Impact of Flavored Tobacco Across Populations: From Neuroscience to Policy.

Shervin Assari, Ali Farhoudian

Abstract readReview
In one paragraph

Review in Basic and clinical neuroscience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Shervin AssariDepartment of Internal Medicine, College of Medicine, Charles R. Drew University of Medicine and Science, Los Angeles, United States.ORCID https://orcid.org/0000-0002-5054-6250
Ali FarhoudianDepartment of Psychiatry, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.ORCID 0000-0003-0126-2814

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Flavored tobacco products engage neural reward and sensory integration pathways, increasing appeal and dependence, particularly among youth people. Although tobacco control policies such as taxation and adoption of smoke-free laws have reduced overall tobacco use, their benefits are unevenly distributed across socioeconomic and racial/ethnic groups. This study, by reviewing evidence from neuroscience, epidemiology, and public policy, aims to examine how flavored tobacco and major tobacco control strategies differentially affect population. We focus on tobacco taxation, smoke-free laws, and complementary policies, with attention to policy reach, enforcement, and structural inequities. Neuroscientific findings showed that flavor additives enhance reward and mask aversive properties of tobacco, amplifying vulnerability among targeted populations. While taxes and smoke-free laws reduce tobacco use at the population level, disadvantaged minority groups often experience weaker benefits due to uneven policy adoption, limited enforcement, targeted industry marketing, and reduced access to cessation resources. The Minorities' Diminished Returns framework helps explain why similar policy exposure yields smaller health gains in marginalized populations. Tobacco control policies are effective but not inherently equitable. Reducing tobacco-related inequalities requires integrating flavor restrictions with uniformly applied taxation, comprehensive smoke-free protections, strong enforcement, and accessible cessation support.

Indexed as

Ethnic groupsHealth equityHealth status disparitiesLaw enforcementMinority healthNeurosciencesPublic policyRacial groupsSmoke-free lawsSmoking cessationSmoking preventionSocial determinants of healthSocioeconomic factorsTobacco control policiesTobacco smoke pollutionTobacco taxation

Identifiers

PMID42238751
PMCPMC13228111

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.